Mayne Pharma Inc 2022-06-29 Health serious FDA
Health · FDA · Recall #FDA-D-1152-2022
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton … Recall
Issued June 29, 2022 · Mayne Pharma Inc
In June 2022, Mayne Pharma Inc recalled the Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton …, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
What you should do
- 1 Stop using Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton … right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Mayne Pharma Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Mayne Pharma Inc
- Category
- Health
- Recall date
- June 29, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the US Market
- Recall number
- FDA-D-1152-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Mayne Pharma Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.